ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

11,504Medicare Part D Prescriptions Filled, Including Refills
$662K Total Retail Price of All Prescriptions
307 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 595 500
LEVOTHYROXINE SODIUM 378 299
OMEPRAZOLE 361 325
AMLODIPINE BESYLATE 353 308
WARFARIN SODIUM 320 235
FUROSEMIDE 275 246
METOPROLOL TARTRATE 264 216
NAMENDA 260 257
DONEPEZIL HCL 259 259
LISINOPRIL 246 232
HYDROCODONE-ACETAMINOPHEN 206 160 S3
SERTRALINE HCL 189 173
LOSARTAN POTASSIUM 179 143
POTASSIUM CHLORIDE 175 159
METFORMIN HCL 164 128
METOPROLOL SUCCINATE 159 141
HYDROCHLOROTHIAZIDE 150 144
GLIPIZIDE 147 142
GABAPENTIN 144 116
LANTUS 144 115
DIOVAN 139 125
ALBUTEROL SULFATE 136 135
IPRATROPIUM BROMIDE 127 126
LOVASTATIN 117 117
MIRTAZAPINE 115 115
ATENOLOL 113 89
ALENDRONATE SODIUM 111 109
ATORVASTATIN CALCIUM 102 93
CARVEDILOL 99 97
IBUPROFEN 95 49
PANTOPRAZOLE SODIUM 94 57
JANUVIA 93 88
TRIAMCINOLONE ACETONIDE 92 71
DIVALPROEX SODIUM 89 76
PREDNISONE 88 73
ESCITALOPRAM OXALATE 86 76
ADVAIR DISKUS 82 71
QUETIAPINE FUMARATE 80 65
CITALOPRAM HBR 78 78
PROAIR HFA 78 45
RISPERIDONE 76 64
SPIRIVA 73 73
RANITIDINE HCL 73 71
TAMSULOSIN HCL 71 70
ZOLPIDEM TARTRATE 65 50
DIGOXIN 63 48
LOSARTAN-HYDROCHLOROTHIAZIDE 63 62
AZITHROMYCIN 62 53
FAMOTIDINE 61 61
TRAZODONE HCL 61 61
CRESTOR 60 50
SYMBICORT 57 43
OXYBUTYNIN CHLORIDE 56 56
EXELON 56 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 48
LACTULOSE 51 50
LEVETIRACETAM 50 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.